Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-13

Clinical Trial Update: An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis

View source ↗

Summary

This is an observational study update evaluating changes in disease activity and treatment patterns when upadacitinib is given alone or with methotrexate in adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)
  • Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Psoriatic Arthritis | Status: ACTIVE_NOT_RECRUITING